                               SEQUENCE LISTING

<110> MEMORIAL SLOAN KETTERING CANCER CENTER
 
<120> IMAGING COMPOUNDS SELECTIVE FOR NAV1.7

<130> 115872-2218

<140> PCT/US2021/036338
<141> 2021-06-08

<150> 63/037,150
<151> 2020-06-10

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Lysine or absent

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Lysine or absent

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 1
Xaa Tyr Cys Gln Xaa Phe Leu Trp Thr Cys Asp Ser Glu Arg Pro Cys 
1               5                   10                  15      


Cys Glu Gly Leu Val Cys Arg Leu Trp Cys Xaa Ile Asn 
            20                  25                  


<210> 2
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Tyr Cys Gln Lys Phe Leu Trp Thr Cys Asp Ser Glu Arg Pro Cys Cys 
1               5                   10                  15      


Glu Gly Leu Val Cys Arg Leu Trp Cys Lys Ile Asn 
            20                  25              


<210> 3
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> L-propargylglycine

<400> 3
Xaa Tyr Cys Gln Lys Phe Leu Trp Thr Cys Asp Ser Glu Arg Pro Cys 
1               5                   10                  15      


Cys Glu Gly Leu Val Cys Arg Leu Trp Cys Lys Ile Asn 
            20                  25                  


<210> 4
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> L-propargylglycine

<400> 4
Tyr Cys Gln Xaa Phe Leu Trp Thr Cys Asp Ser Glu Arg Pro Cys Cys 
1               5                   10                  15      


Glu Gly Leu Val Cys Arg Leu Trp Cys Lys Ile Asn 
            20                  25              


<210> 5
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (26)..(26)
<223> L-propargylglycine

<400> 5
Tyr Cys Gln Lys Phe Leu Trp Thr Cys Asp Ser Glu Arg Pro Cys Cys 
1               5                   10                  15      


Glu Gly Leu Val Cys Arg Leu Trp Cys Xaa Ile Asn 
            20                  25              


